Navigation Links
Mass Financial Corp. Launches Lawsuit Against Elekta AB, Seeks Substantial Damages
Date:11/5/2007

HONG KONG, Nov. 5 /PRNewswire/ -- Mass Financial Corp. ("MASS") Hong Kong announced today that it has filed a lawsuit in the Supreme Court of British Columbia, Canada against Elekta AB, ("Elekta") Stockholm, Sweden and other for breach of contract and contract interference. In the lawsuit we seek injunctive relief and substantial damages.

Michael Smith, President of MASS said the lawsuit involves our proprietary magneto-encephalography "MEG" technologies, (a medical imaging device used for neurological research and diagnostics). "What is very shocking is that Elekta has complained about Chinese companies that have copied Elekta's technology and used it without authority in China and in the international markets," said Mr. Smith. "Why are they now doing the same with our subsidiary? We understand their MEG technology is inferior to our VSM/C.T.F. System technology and wish to put on notice that any hospitals or persons who have or will in the future conspire with Elekta to the detriment of MASS will be included in the lawsuit."

Elekta has stated that its MEG device has never generated a profit and that Elekta would like to liquidate the division but fears that such an admission of failure would negatively affect their stock market price.

Michael Smith continued, this lawsuit is of utmost importance to all small, growing companies in any industry. It is really about a big company trying to intimidate a small company, while using very oppressive tactics. I want to ensure our people as well as Elekta, we will exercise all legal means at our disposal to block and expose this uncompetitive conduct. MASS will continuously report to the public Elekta's ongoing behaviour.

Michael Smith continued, with our lawsuit it should be noted we have tried to communicate with Elekta. Such a lawsuit is only necessary against companies when their management refuse to engage in a professional dialogue and when there is no corporate governance practiced by it
'/>"/>

SOURCE Mass Financial Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. WorldHeart Appoints David Pellone Chief Financial Officer
2. Align Technology Executive to Present at Upcoming Financial Conferences
3. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
4. Martek Announces Third Quarter 2007 Financial Results
5. Retired NYPD Lieutenants William E. Keegan, Jr., Owen McCaffery and John Moran and Tom Thees, a former COO in the financial industry, announce today the formation of H.E.A.R.T (Healing Emergency Aid Response Team) 911.
6. Presidential Candidates Address Health, Financial Security at AARPs Life@50+
7. VNUS Medical Technologies Announces Resignation of Chief Financial Officer and VP, Finance & Administration
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
10. Peoples United Financial CEO Has Surgery
11. Assured Pharmacy Retains Empire Financial Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, ... length may be showing a genetic propensity for obesity as ... have been linked to increased body fat, but the same ... muscle, the researchers said. At 1 year, kids with ... and 3, however, these genes were linked to excessive weight ...
(Date:10/22/2014)... Maureen Salamon HealthDay ... A crucial part of conventional in vitro fertilization (IVF) -- ... instead take place in a device inside the vagina, new ... contend that the device, called an INVOcell, might sharply cut ... also make the technology more accessible to those who don,t ...
(Date:10/20/2014)... October 20, 2014 The newly updated ... source of thousands of facts, figures and forecasts on ... 68 medical sector forecast categories the Worldwide Medical ... regional and national views on the worldwide medical market ... The report gives you data for 2010-2019, covering each ...
(Date:10/20/2014)... 2014 ASCNYC (ascnyc.org) is a ... New Yorkers living with HIV/AIDS and other chronic ... recovery and self-sufficiency. Each year, ASCNYC spotlights selected ... through their tireless efforts. , Savills Studley ... has been selected as this year’s honoree for ...
(Date:10/20/2014)... October 20, 2014 Zereana Jess-Huff, a 34-year-old ... Maryland 2014 on a platform to think outside the bra. ... uses her position to raise awareness about women’s other lady ... breast cancer. You say the color pink and everybody knows ... for a fact that it has not been won when ...
Breaking Medicine News(10 mins):Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 2Health News:Ovarian Cancer Survivor Mrs. Maryland Urges Media to Think Outside the Bra 3
... Parker Named Interim Chief Financial Officer , , ... MDTH ), a healthcare provider focused on high ... cardiovascular disease, today announced that Art Parker, Senior Vice ... Financial Officer. Parker replaces Jeff Hinton, whose employment ...
... Endo Pharmaceuticals (Nasdaq: ENDP ) announced today that it will ... 10, 2009 at 4:30 pm Eastern Time. Dave Holveck, President and ... programs. , , The presentation will be webcast live and can ... the investors section. , , About Endo ...
... Scientists make strides in finding ways to slow tumor ... A protein called PHD2 that regulates blood vessel growth ... researchers who analyzed levels of the protein in tumor ... expression of PHD2, researchers at Stanford University School of ...
... CORAL GABLES, FL (June 5, 2009)--Dengue Fever (DF) and ... viral diseases in the World. Around 50-100 million cases ... of suffering this debilitating and sometimes fatal disease. Dengue ... an interdisciplinary team of researchers from the University of ...
... Interleukin Genetics, Inc. (NYSE Amex: ... President of Research and Development, will present findings that ... to weight-loss in overweight individuals at the American Diabetes ... Aziz will present the Company,s research at 8 a.m. ...
... --- Neighborhoods with restaurants, entertainment, cultural facilities and ethnic ... Chicago than neighborhoods where residents are less likely to ... facilities. , Published in the spring 2009 ... Immunology , the two-year study led by Ruchi Gupta, ...
Cached Medicine News:Health News:Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference 2Health News:Researchers develop the first climate-based model to predict Dengue fever outbreaks 2Health News:Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting 2Health News:Interleukin Genetics to Present Research Linking Perilipin Genes to Diet Response at the ADA Annual Meeting 3Health News:Asthma rates and where you live 2
(Date:10/22/2014)... -- AVACEN Medical announced today that its AVACEN 100 ... by the U.S. Food and Drug Administration. This clearance ... Internet for: the temporary relief of joint pain ... sprains . Logo - http://photos.prnewswire.com/prnh/20141021/153513 ... a sophisticated medical device incorporating over 3,000 firmware instructions ...
(Date:10/22/2014)... , Oct. 21, 2014   BioNano Genomics ... latest genomics research centers to purchase an ... the National Cancer Institute (NCI), NIH Intramural Sequencing ... Before Irys, obtaining a comprehensive view of a ... sequencing (NGS) does not deliver the scalability or ...
(Date:10/22/2014)... , Oct. 22, 2014 InVivo Therapeutics Holdings ... is revolutionizing spinal cord injury (SCI) treatment ... shown to outperform in tissue regrowth in the spinal ... Made from an FDA approved polymer, the scaffold ultimately ... harmless to the human body. NVIV has recently attracted ...
Breaking Medicine Technology:AVACEN Medical Announces FDA Clearance of First Medical Device with Internal Game Mode 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3
... ImmusanT, Inc. announced today it has raised ... Healthcare Partners LLC to advance development of the ... monitoring tool for celiac disease. The proceeds will ... to the point of demonstrating proof-of-concept. ImmusanT expects ...
... Dec. 13, 2011 IRIDEX Corporation (Nasdaq: IRIX ... for Health and Clinical Excellence (NICE) has issued a ... is not as cost effective as conventional laser photocoagulation ... treatment for diabetic macular edema (DME), a swelling of ...
Cached Medicine Technology:ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease 2ImmusanT Raises $20 Million in Series A Financing to Advance Immunotherapeutic and Diagnostic for Celiac Disease 3UK's National Health System Rejects Drug Therapy for Diabetic Macular Edema 2UK's National Health System Rejects Drug Therapy for Diabetic Macular Edema 3
The Vitek 2 is a fully automated bacteriology system that performs bacterial identification and susceptibility testing analysis using a standard inoculum. It detects resistance and helps combat bacte...
IDS Rapid Yeast Plus, a microbial identification system....
IDS Rapid NH, a microbial identification system....
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
Medicine Products: